AOCI at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacific Biosciences of California's AOCI?
- Pacific Biosciences of California (PACB) reported AOCI of -$147K in Q1 2026.
- How has Pacific Biosciences of California's AOCI changed year-over-year?
- Pacific Biosciences of California's AOCI decreased by 138.6% year-over-year, from $381K to -$147K.
- What is the long-term trend for Pacific Biosciences of California's AOCI?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's AOCI has grown at a 40.0% compound annual growth rate (CAGR), from $85K to $457K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.